TY - JOUR
T1 - An autopsied case of metastatic endocrine carcinoma of the pancreas with primary site difficult to identify
AU - Nishimori, Hisakazu
AU - Takahashi, Shunji
AU - Nagasaki, Eijiro
AU - Kobayashi, Takayuki
AU - Yokoyama, Masahiro
AU - Shinozaki, Eiji
AU - Mishima, Yuko
AU - Terui, Yasuhito
AU - Chin, Keisyo
AU - Mizunuma, Nobuyuki
AU - Ito, Yoshinori
AU - Inamura, Kentaro
AU - Hatake, Kiyohiko
N1 - Copyright:
This record is sourced from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
PY - 2005/5
Y1 - 2005/5
N2 - A 40-year-old man suffering from right cheek swelling was first diagnosed with ameloblastoma or anaplastic poorly-differentiated carcinoma of the head and neck region. He received 2 courses of CDDP/TXT chemotherapy (cisplatin 75 mg/m2, docetaxel 80 mg/m2) and achieved a partial response, but his carcinoma of the pancreas recurred. He also achieved a partial response with 2 courses of CBDCA/TXL regimen (carboplatin AUC=6, paclitaxel 200 mg/m2), but later died from his progressive disease. The autopsy revealed a pathological diagnosis of metastatic endocrine carcinoma of the pancreas. This case was close to a cancer with an unknown primary (CUP) site, and several favorable sub-sets of CUP have been identified, which are responsive to systemic chemotherapy. Poorly-differentiated neuroendocrine carcinomas like this case are highly sensitive to chemotherapy, and a careful pathological diagnosis may clarify its sensitivity to chemotherapy and the prognosis.
AB - A 40-year-old man suffering from right cheek swelling was first diagnosed with ameloblastoma or anaplastic poorly-differentiated carcinoma of the head and neck region. He received 2 courses of CDDP/TXT chemotherapy (cisplatin 75 mg/m2, docetaxel 80 mg/m2) and achieved a partial response, but his carcinoma of the pancreas recurred. He also achieved a partial response with 2 courses of CBDCA/TXL regimen (carboplatin AUC=6, paclitaxel 200 mg/m2), but later died from his progressive disease. The autopsy revealed a pathological diagnosis of metastatic endocrine carcinoma of the pancreas. This case was close to a cancer with an unknown primary (CUP) site, and several favorable sub-sets of CUP have been identified, which are responsive to systemic chemotherapy. Poorly-differentiated neuroendocrine carcinomas like this case are highly sensitive to chemotherapy, and a careful pathological diagnosis may clarify its sensitivity to chemotherapy and the prognosis.
UR - http://www.scopus.com/inward/record.url?scp=19544374527&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=19544374527&partnerID=8YFLogxK
M3 - Article
C2 - 15918570
AN - SCOPUS:19544374527
VL - 32
SP - 671
EP - 673
JO - Japanese Journal of Cancer and Chemotherapy
JF - Japanese Journal of Cancer and Chemotherapy
SN - 0385-0684
IS - 5
ER -